First Hydrogen Corp. (TSXV: FHYD) (OTC Pink: FHYDF) has signed a definitive agreement to acquire a 60% interest in Exodus Actuation Solutions Inc., gaining access to a portfolio of robotics-related patents and intellectual property.
Under the September 9 agreement, First Hydrogen will issue two million common shares in stages and provide US$2 million in staged financing. The funding will be governed by budgets mutually agreed upon by the companies and used to advance Exodus’s technology.
The transaction remains subject to acceptance by the TSX Venture Exchange. First Hydrogen will also pay an undisclosed finder’s and consulting fee to a third party under exchange policies.
Exodus, referred to as RoboticsCo in the announcement, owns or licenses 26 issued and 10 pending patents covering actuation gearboxes, motors and related robotics technologies. Actuators and gearboxes control how robotic joints and other moving components generate force and motion.
First Hydrogen said more than 500 motors and gearboxes based on the technology have been manufactured and shipped. The company also said the components have been tested or used by businesses in the robotics, automotive and packaging industries. Customer identities, product revenue and order values were not disclosed.
The technology is designed to improve speed, torque density, precision and energy efficiency while reducing equipment size, noise and cost. Potential applications include humanoid robots, robotic arms, collaborative robots, automated assembly systems, material-handling equipment and other motion-control platforms.
Alongside the agreement, First Hydrogen announced the formation of First Humanoid Corp., a wholly owned subsidiary focused on humanoid robotics, autonomous systems and artificial intelligence. The subsidiary is intended to hold, develop and commercialize robotics-related intellectual property.
Despite its name, First Hydrogen has expanded beyond its original focus on hydrogen-powered commercial vehicles and green-hydrogen infrastructure. Its recent initiatives include robotic ground vehicles, drone technology and small modular reactor research.
The latest announcement represents progress from the binding letter of intent announced in February. However, it does not establish that First Hydrogen has developed a completed humanoid robot or secured customers for one.
The agreement also creates financing and execution risks. First Hydrogen must supply US$2 million in staged funding, while the issuance of two million shares may dilute existing shareholders. The release did not disclose a valuation for Exodus, financial statements for the business or a timetable for generating robotics revenue.
Upcoming Catalysts
The first near-term milestone is TSX Venture Exchange acceptance of the transaction. Subsequent updates could address the staged share issuances, funding budgets and integration of Exodus’s intellectual property.
Investors may also watch for technical details about First Humanoid’s proposed platform, prototype development, named commercial partners and evidence of customer orders. First Hydrogen has not provided a launch date for a commercial humanoid robot.
Sources
- First Hydrogen signs definitive robotics agreement, September 9, 2026
- First Hydrogen enters binding letter of intent with RoboticsCo, February 23, 2026
- First Hydrogen corporate website
Editorial Disclosure
This article is based entirely on publicly available company announcements and corporate information. Next Gen Tech Stocks was not compensated by First Hydrogen Corp. for this coverage, and the author holds no position in the securities mentioned. Company statements regarding patents, testing, manufacturing and technology performance have not been independently verified. The transaction remains subject to TSX Venture Exchange acceptance and requires staged financing and share issuance. First Hydrogen is a speculative small-cap company exposed to commercialization, financing, dilution, regulatory and technical-execution risks. Information is current as of September 9, 2026. This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Read the full disclaimer.
